Navigation Links
Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention
Date:10/31/2011

SANTA ROSA, Calif., Oct. 31, 2011 /PRNewswire/ -- Claret Medical, Inc. announced today that its Montage System has received CE Mark approval as the world's first complete system of filtration to protect both carotid arteries simultaneously. The 6F catheter is delivered via radial or brachial access, providing complete neuro protection during intravascular procedures such as Transcatheter Aortic Valve Intervention (TAVI).  The unique design of the Montage System provides for not only neuro-protection from debris, but also for capturing and removing potential stroke causing embolic material from the body. "The CE Mark approval for the Montage System is an exciting new step forward to potentially reduce stroke rates in TAVI and other vascular procedures," said Prof. Eberhard Grube, M.D., F.A.C.C., F.S.C.A.I., Director of the Structural Heart Program at University Hospital in Bonn, Germany.  "The timing of this innovation could not be better, in that it has the potential to change the way physicians view TAVI in their practice."

(Logo:  http://photos.prnewswire.com/prnh/20111031/SF96703LOGO)

"The Montage System was surprisingly elegant and simple to deliver," notes Alexander Abizaid Director, Catheterization Laboratory, Institute Dante Pazzanese, Sao Paolo, Brazil.  "We, along with other investigators, were astounded at the volume of debris we found in the filters and were delighted we could provide a solution to help capture and remove this material from the patient's vascular circulation."  

This is the second product approval for Claret Medical in 2011.  These approvals were supported by data from the clinical trial in Europe, which included 30-day patient follow-up.  "The CE Mark approval for the Montage System is an important milestone for Claret, and stems from the incredible dedication of our team to improving patient-care during TAVI,
'/>"/>

SOURCE Claret Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - ... today,announced that data from a 36-week, randomized, ... oral 0.6 mg,dose of laquinimod given daily ... by 38 percent in RRMS,patients and was ...
... pivotal phase III study in women with recurrent ... 2007,/PRNewswire-FirstCall/ -- A new study further supports the ... being,studied for the treatment of ovarian cancer. The ... protein, which triggers,a series of events that selectively ...
Cached Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5
(Date:5/18/2013)... Medical device company, FlexLeg, LLC, last week ... mobility aid with its namesake, the FlexLeg. The device ... alternative that injured individuals can use to walk on ... remain active and walk during a typical 6-8 week recovery ... to ensure those who need the device most are able ...
(Date:5/18/2013)... Phoenix, Arizona (PRWEB) May 18, 2013 ... umbrella – two health and wellness centers and one ... at all three locations, the weekend of May 25th ... personnel and celebrating Memorial Day. All events ... , Saturday, May 25th , Elements Therapeutic Dispensary , ...
(Date:5/17/2013)... 18, 2013. Chronic trauma can inflict lasting damage to ... studies of people with post-traumatic stress disorder, or PTSD, ... in response to stressful tasks, such as recalling a ... threatening face. Now, researchers at NYU School of Medicine ... the brains of combat veterans with PTSD in the ...
(Date:5/17/2013)... 2013 Allen J. Schultz, D.D.S., is making ... treatment available to residents of San Juan Capistrano. ... tissue rather than relying on a scalpel to cut the ... that works on tightly defined wavelengths to target the diseased ... intact. , Only about one in every hundred dental professionals ...
(Date:5/17/2013)... Spring floods, summer droughts and temperature extremes take ... them. Help gardens recover from the crazy temperature and ... Myers suggests the following steps to revive gardens and ... the current condition of the landscape. Remove dead plants ... disease organisms that can infest healthy plantings. Consider replacing ...
Breaking Medicine News(10 mins):Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 3
... a cost-effective form of treatment for Americans,with ... Patients with,diabetes who participate in a program ... improvements in glucose control,physical performance, and body ... the November 2008 issue of Physical Therapy ...
... PURCHASE, N.Y., Oct. 31 Nutrition 21, Inc.,(Nasdaq: ... that,help consumers manage blood sugar levels, improve cardiovascular health,enhance ... results -- prior to the opening of the market ... of fiscal year 2009, ended,September 30, 2008. The Company ...
... more dangerous if publicized , , FRIDAY, Oct. 31 (HealthDay ... the threat of infectious diseases, Canadian researchers say. , ... to be regarded as especially dangerous by the public, ... tend to focus on rare and dramatic events. When ...
... Oct. 31 Blue Cross Blue Shield of Michigan ... bomb threat,received this morning., The closings affect Blue ... and Bricktown Customer Service Center,buildings. The company,s office building ... employees who work in the impacted facilities are,being sent ...
... have previously shown that E2 and P4 have clear ... changes during early H. pylori infection. Recently, Ohtani et ... in H. pylori-infected InGas mice. Other studies have demonstrated ... gastric mucosa. ER and PR have been reported in human, ...
... Your Vet for a Healthy Pet(R), contest sponsored ... Inc., DENVER, Oct. 31 Veterinarians provide ... for long, healthy and happy lives. To,recognize their ... for the "Thank Your Vet for a Healthy ...
Cached Medicine News:Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 2Health News:New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients 3Health News:Nutrition 21 to Report Preliminary First Quarter Fiscal Year 2009 Financial Results on Thursday, November 13, 2008 2Health News:Media Affects Public Perception of Infectious Diseases 2Health News:Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils 2Health News:Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbils 3Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 3
... Surgical Markers allows the surgeon ... with a scrub-resistant, gentian violet ... are provided sterile, with a ... in peel pouches. Micro tip ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Broad tip, gentian violet, sterile, disposable...
Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide....
Medicine Products: